Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Lili Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory of Liaocheng Peoples' Hospital, Liaocheng, Shandong, China. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human papillomavirus (HPV) infection can lead to HPV‐related cancer in men, including the anus, penile, and oropharyngeal cancers and precancerous lesions. This study retrospectively investigated HPV prevalence and genotype distribution in Liaocheng men between 2016 and 2022. The total HPV positive rate was 64.87% (2388/3681, 95% confidence interval [CI]: 63.32%–66.40%), where high risk (HR)‐HPV and low risk (LR)‐HPV accounted for 42.49% (1564/3681, 95% CI: 40.90%–44.09%) and 69.71% (2566/3681, 95% CI: 68.20%–71.17%), respectively. The mixed HPV infection rate of two and more genotypes was 35.72%. The infection rate of HR‐HPV increased with the number of positive cases annually from 2016 (16.91%) to 2022 (46.59%). The most common HR‐HPV genotypes were HPV16 (11.60%), HPV52 (6.95%), and HPV59 (6.28%), whereas the least common HR‐HPV was HPV26. The most common LR‐HPV genotypes were HPV6 (56.99%), HPV11 (23.79%), and HPV43 (6.37%). The 9 v HPV vaccine preventable for LR‐HPV and HR‐HPV accounted for 80.78% and 30.40%, respectively, in this study. Most HPV‐positive patients aged 1–86 were in the 30–39 age group. This study confirmed that HPV prevalence in Liaocheng men was common and diverse. HPV16, HPV52, and HPV59 are widely distributed in Liaocheng men, and the male HR‐HPV infection rate remained high in this region. Regarding public health and cancer prevention, it is recommended and effective to include the HPV vaccination in the national vaccination program for men.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Central Laboratory of Liaocheng Peoples' Hospital, Liaocheng, Shandong, China.
- School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Shandong, China.
- Department of Dermatology Liaocheng Peoples' Hospital, Liaocheng, Shandong, China.
- Clinical Laboratory of Liaocheng Peoples' Hospital, Liaocheng, Shandong, China.
ORCID-Profile: Lili Zheng
Zitieren
APA
Zheng, L., Zheng, L., Chen, S., Liu, W., Qi, J., & Li, K. (2024). Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022. Journal of Medical Virology. https://doi.org/10.1002/jmv.29360
Vancouver
Zheng L, Zheng L, Chen S, Liu W, Qi J, Li K. Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022. Journal of Medical Virology. 2024. doi:10.1002/jmv.29360
BibTeX
@article{Zheng2024,
author = {Zheng, Lili and Zheng, Liyuan and Chen, Shuangfeng and Liu, Wenhui and Qi, Jieyu and Li, Ke},
title = {Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29360}
}
EUVIMED